The ESMO Colloquia are innovative new sessions within the Congress programme that bring together top experts to discuss evolving areas of interest to the oncology community.
The Colloquia are organised by ESMO and supported by the industry in a unique collaboration making them the perfect complement to the scientific and education programme of the Congress.
Thursday, 4 July 2019
ESMO Colloquium: Metastatic gastrointestinal cancer: How to deal with the complexity of multiple available drugs across lines of treatment?
Room 115-116, 13:15-14:45
This educational activity is provided by ESMO and supported by Lilly Oncology.
View the ESMO Colloquium details
- Review the optimal treatment options in successive lines of available therapies
- Discuss best sequencing based on level of evidence
- Learn about the use of biomarker for decision making
- Analyse the present guidelines, algorithms and ESMO-MCBS scores as tools for selection